Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
Presentation Title: “Role of Site-Specific ADP-Ribosylation in Cancer”
The San Antonio Pediatric Cancer Symposium (SAPCS), hosted by the Greehey Children's Cancer Research Institute at UT Health San Antonio and in conjunction with the Mays Cancer Center, will bring together some of the most respected childhood cancer researchers from academia and industry; to discuss how advances in basic and translational sciences are impacting tomorrow's therapies and diagnoses. More info (including sessions, speakers, and registration) is coming soon!